EDITORIAL |
|
Nephrotic syndrome at children
|
4-16 |
HOTLINE TOPIC |
|
V.V. Cheltsov
NSAID-induced nephropathies
|
17-23 |
|
V.M. Ermolenko, N.N. Filatova
Recormon: 20 years of success in clinical practice
|
24-27 |
|
L.V. Kozlovskaya, Yu.S. Milovanova, L.Yu. Milovanova
Optimal target hemoglobin level in chronic kidney disease patients, treated with erythropoesis-stimulating agents: controversial questions
|
28-35 |
ORIGINAL PAPERS |
|
S.A. Savelieva, A.A. Kriachkova, I.M. Kutyrina, M.V. Shestakova
Cardio-renal interrelations in patients with diabetes mellitus type 2 and obesity
|
36-40 |
|
E.V. Shutov, S.V. Lashutin, V.S. Luosev, G.V. Riabinskaya, E.A. Gorelova, E.I. Levankovskaya
New opportunities in treatment of secondary hyperparathyreoidism in patients on program haemodialysis with combination of cinacalcet and low doses of low doses of vitamin D sterols
|
41-46 |
|
D.E. Kutepov, A.V. Popov, A.V. Tsigankov, M.G. Vershinina
Long-term sustained low efficiency dialysis in treatment of patients with cardiorenal syndrome
|
47-50 |
|
A.N. Maksudova, I.G. Salikhov, S.V. Maltsev
Outcomes of dysmetabolic nephropathies: results of the retrospective study
|
51-53 |
PAEDIATRIC NEPHROLOGY |
|
Yu.A. Leont’eva, S.S. Paunova, A.G. Kucherenko, I.E. Smirnov, V.M. Novikova, L.A. Ravenkova, E.A. Temerina, N.L. Goltsova, O.V. Anokhina
Urinary concentration of matrix metalloproteinases-2 and -9 and their tissue inhibitors in children with pyelonephritis
|
54-57 |
|
N.E. Kon’kova, M.S. Ignatova, V.V. Dlin
Nephroprotective effect of angiotensin-converting enzyme inhibitors in children with Alport syndrome
|
58-63 |
EXPERIMENTAL STUDIES |
|
N. Zaikova, V. Dlin, V. Petrovich, V. David, P. Stratulat
The pathomorphological changes in the kidneys of rats in the experimental simulations of infection and non-infected vesicoureteric reflux (experimental study)
|
64-71 |
CASE REPORTS |
|
A.A. Pulin, E.Yu.Gornostaeva, S.V. Roschupkina, S.S. Gririna, L.V. Kozlovskaya
Succesful rituximab therapy of membranous nephropathy, resistant to standard immunosupressive treatment
|
72-77 |
EPONYM |
|
de Toni–Debre–Fanconi disease (syndrome)
|
78-79 |
Русский
